ITFISA
VRTX icon

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Vertex Pharmaceuticals VRTX Stock Holding History

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-280
Closed -$130K – 205
2024
Q3 		$130K Sell
280
-195
-41% -$93.7K 0.05% 131
2024
Q2 		$223K Buy
475
+120
+34% +$52.1K 0.08% 109
2024
Q1 		$142K Buy
+355
New +$150K 0.06% 125

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's VRTX Position: Q4 2024 in Review

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold out of Vertex Pharmaceuticals (VRTX) in Q4 2024, closing a stake of 280 shares — an estimated $130K sold.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in VRTX in Q1 2024 and held it in 3 quarters. The position peaked at $223K in Q2 2024. 1,559 funds tracked by Wall St. Rank hold VRTX as of Q4 2024.

  • Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna reported no remaining Vertex Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold 280 Vertex Pharmaceuticals shares in Q4 2024, an estimated $130K.
  • Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in Vertex Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's Vertex Pharmaceuticals position peaked at $223K in Q2 2024.
  • 1,559 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2024.

Based on Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's 13F filing for Q4 2024, filed 28 Aug 2025.